Lamotrigine Extended Release
- Product NDC
- 49884-604
- 11-digit product format
- 498840604
- Labeler code
- 49884
- Product ID
- 49884-604_3c26caa3-84f9-442d-b752-9dda35d0bacb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lamotrigine extended release
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Par Pharmaceutical, Inc.
- Application
- ANDA201791
- Marketing category
- ANDA
- Marketing start
- 2013-01-18
- Marketing end
- 0000-00-00
- Substance
- LAMOTRIGINE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Anti-epileptic Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 49884-604 | D | Discontinued by firm | 2026-10-23 | ||
| excluded package | package | 49884-604 | 49884-604-01 | D | Discontinued by firm | 2026-10-23 | |
| excluded package | package | 49884-604 | 49884-604-05 | D | Discontinued by firm | 2026-10-23 | |
| excluded package | package | 49884-604 | 49884-604-11 | D | Discontinued by firm | 2026-10-23 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A201791-001 | LAMOTRIGINE | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | ||
| A201791-002 | LAMOTRIGINE | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | ||
| A201791-003 | LAMOTRIGINE | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | ||
| A201791-004 | LAMOTRIGINE | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | ||
| A201791-005 | LAMOTRIGINE | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | ||
| A201791-006 | LAMOTRIGINE | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A201791-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A201791-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A201791-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A201791-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A201791-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A201791-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A201791-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A201791-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A201791-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A201791-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A201791-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A201791-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A201791-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A201791-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A201791-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A201791-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A201791-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A201791-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2013-01-18 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A201791-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201791-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201791-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201791-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201791-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201791-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201791-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201791-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201791-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201791-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201791-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201791-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201791-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201791-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201791-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201791-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201791-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201791-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201791-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201791-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201791-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201791-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2013-01-18 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-07-19 19:46 UTC | 2019-07 | A201791-005 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A201791-006 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A201791-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A201791-002 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A201791-003 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A201791-004 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A201791-005 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A201791-006 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A201791-001 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A201791-002 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A201791-003 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A201791-004 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A201791-005 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A201791-006 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A201791-001 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A201791-002 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A201791-003 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A201791-004 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A201791-005 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A201791-006 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A201791-001 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A201791-002 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A201791-003 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A201791-004 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A201791-005 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A201791-006 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A201791-001 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A201791-002 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A201791-003 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A201791-004 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A201791-005 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A201791-006 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A201791-001 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A201791-002 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A201791-003 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A201791-004 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A201791-005 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A201791-006 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A201791-001 | AB | 1 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A201791-002 | AB | 1 | 3f0d92c62455… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 14a9502b-3d70-0496-a7e1-b16edaa005b8 | Product name | 5 | 20250423 |
| 16d731ed-ff3e-e9a1-3e3e-1ef6b6be40a0 | Product name | 7 | 20250401 |
| e29d8e8b-4bc8-ebaf-f18e-e35287b19d6a | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49884-604-01 | Lamotrigine Extended Release | 100 in 1 BOTTLE | TABLET | 100 | 21 | |
| 49884-604-05 | Lamotrigine Extended Release | 500 in 1 BOTTLE | TABLET | 500 | 21 | |
| 49884-604-11 | Lamotrigine Extended Release | 30 in 1 BOTTLE | TABLET | 30 | 21 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49884-604-11 | EA - Each | 49884-604 | 18bd48db-989c-409d-a439-4567a250038b | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LAMOTRIGINE | ACTIVE INGREDIENT | U3H27498KS | LAMOTRIGINE EXTENDED RELEASE TABLET [PAR PHARMACEUTICAL INC.] | 7 | |
| LAMOTRIGINE | ACTIVE MOIETY | U3H27498KS | LAMOTRIGINE EXTENDED RELEASE TABLET [PAR PHARMACEUTICAL INC.] | 7 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | LAMOTRIGINE EXTENDED RELEASE TABLET [PAR PHARMACEUTICAL INC.] | 7 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | LAMOTRIGINE EXTENDED RELEASE TABLET [PAR PHARMACEUTICAL INC.] | 7 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | LAMOTRIGINE EXTENDED RELEASE TABLET [PAR PHARMACEUTICAL INC.] | 7 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | LAMOTRIGINE EXTENDED RELEASE TABLET [PAR PHARMACEUTICAL INC.] | 7 | |
| METHACRYLIC ACID | INACTIVE INGREDIENT | 1CS02G8656 | LAMOTRIGINE EXTENDED RELEASE TABLET [PAR PHARMACEUTICAL INC.] | 7 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | LAMOTRIGINE EXTENDED RELEASE TABLET [PAR PHARMACEUTICAL INC.] | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 850087 | lamoTRIgine 100 MG 24HR Extended Release Oral Tablet | PSN | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 900156 | lamoTRIgine 200 MG 24HR Extended Release Oral Tablet | PSN | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 900164 | lamoTRIgine 25 MG 24HR Extended Release Oral Tablet | PSN | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 1146690 | lamoTRIgine 250 MG 24HR Extended Release Oral Tablet | PSN | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 1098608 | lamoTRIgine 300 MG 24HR Extended Release Oral Tablet | PSN | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 850091 | lamoTRIgine 50 MG 24HR Extended Release Oral Tablet | PSN | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 850087 | 24 HR lamotrigine 100 MG Extended Release Oral Tablet | SCD | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 900156 | 24 HR lamotrigine 200 MG Extended Release Oral Tablet | SCD | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 900164 | 24 HR lamotrigine 25 MG Extended Release Oral Tablet | SCD | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 1146690 | 24 HR lamotrigine 250 MG Extended Release Oral Tablet | SCD | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 1098608 | 24 HR lamotrigine 300 MG Extended Release Oral Tablet | SCD | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 850091 | 24 HR lamotrigine 50 MG Extended Release Oral Tablet | SCD | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 850087 | lamotrigine 100 MG 24 HR Extended Release Oral Tablet | SY | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 900156 | lamotrigine 200 MG 24 HR Extended Release Oral Tablet | SY | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 900164 | lamotrigine 25 MG 24 HR Extended Release Oral Tablet | SY | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 1146690 | lamotrigine 250 MG 24 HR Extended Release Oral Tablet | SY | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 1098608 | lamotrigine 300 MG 24 HR Extended Release Oral Tablet | SY | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
| 850091 | lamotrigine 50 MG 24 HR Extended Release Oral Tablet | SY | fb59c76a-9b6f-40ea-ac3a-58c3195c4377 | 21 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 49884-604-01 | 49884060401 | 100 TABLET in 1 BOTTLE (49884-604-01) | 100 tablet | 2013-01-18 | 0000-00-00 | No | No | Current |
| 49884-604-05 | 49884060405 | 500 TABLET in 1 BOTTLE (49884-604-05) | 500 tablet | 2013-01-18 | 0000-00-00 | No | No | Current |
| 49884-604-11 | 49884060411 | 30 TABLET in 1 BOTTLE (49884-604-11) | 30 tablet | 2013-01-18 | 0000-00-00 | No | No | Current |